BNC Share Price

Open 22.35 Change Price %
High 22.35 1 Day 0.00 0.00
Low 22.29 1 Week 0.00 0.00
Close 22.29 1 Month 0.20 0.91
Volume 1495 1 Year 22.08 10514.29
52 Week High 23.18
52 Week Low 20.15
BNC Important Levels
Resistance 2 22.35
Resistance 1 22.32
Pivot 22.31
Support 1 22.26
Support 2 22.23
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
YRI 4.05 0.75%
TD 65.63 -0.62%
TD 65.63 -0.62%
SC 60.83 -0.44%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
CUM 0.90 13.92%
CUM 0.90 13.92%
ME 0.20 11.11%
ME 0.20 11.11%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
ANX 0.07 -12.50%
ANX 0.07 -12.50%
NKO 0.08 -11.11%
NKO 0.08 -11.11%
NKO 0.08 -11.11%
PNP 3.14 -10.29%
CTU-A 0.19 -9.52%
NCU 0.56 -6.67%
NCU 0.56 -6.67%
More..

Bioniche Life Sciences Inc (TSE: BNC)

BNC Technical Analysis 5
As on 11th Apr 2017 BNC Share Price closed @ 22.29 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.78 & Strong Buy for SHORT-TERM with Stoploss of 11.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
BNC Target for April
1st Target up-side 22.68
2nd Target up-side 23.1
3rd Target up-side 23.52
1st Target down-side 21.5
2nd Target down-side 21.08
3rd Target down-side 20.66
BNC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioniche.com
BNC Address
BNC
231 Dundas Street East
Belleville, ON K8N 1E2
Canada
Phone: 613-966-8058
Fax: 613-966-4177
BNC Latest News
Mackenzie Investments To Launch Active ETF On NEO   Exchange News Direct   - 20th Apr 17
A marijuana breathalyzer stock, the rise of National Bank, and why you need a ...   The Globe and Mail   - 19th Apr 17
Desjardins Launches Initial Suite of Seven Exchange Traded Funds   Canada NewsWire (press release)   - 03rd Apr 17
A tantalizing fixed-income alternative   MoneySense   - 01st Apr 17
Canada's Equity Markets Look Primed for More Upside   ETF Trends   - 31st Mar 17
Goldman Sachs rolls out junk bond ETF: Fund Scan   Financial Planning   - 25th Mar 17
TSX listed corporate dividends and distributions declared March 23   Winnipeg Free Press   - 24th Mar 17
Canadian Banks Could Be In Deep Trouble   ETF Daily News (blog)   - 23rd Mar 17
Purpose Investments Inc. Announces February Distributions   Marketwired (press release)   - 17th Feb 17
Purpose Investments Announces the Launch of Two Innovative Income Funds   Marketwired (press release)   - 26th Oct 16
Interactive Technical Analysis Chart Bioniche Life Sciences Inc ( BNC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Bioniche Life Sciences Inc
BNC Business Profile
Bioniche Life Sciences Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, manufacture, and marketing of proprietary products for the human health markets. Its lead product, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, is a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans, which is in Phase III clinical development. The company was formerly known as Vetrepharm Animal Health Inc. Bioniche Life Sciences Inc. was founded in 1979 and is headquartered in Belleville, Canada.